ArticleBMJ neurology open2026
Screening for mood disorders after stroke: feasibility of a community-based pathway.
Article in BMJ neurology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To assess the prevalence of anxiety and depression 4-6 months poststroke, examine whether demographic factors were associated with response status, and evaluate feasibility outcomes, including acceptability and utility, of a poststroke mood disorder screening programme. Methods: This prospective cohort study included patients aged ≥18 years discharged with ischaemic stroke, transient ischaemic attack or intracerebral haemorrhage between October 2022 and February 2024 from a comprehensive stroke centre in New South Wales, Australia. Exclusion criteria were (a) current or recent patient of a multidisciplinary rehabilitation team, (b) receipt of postdischarge mental health services, (c) discharge to a residential aged care facility, (d) end-of-life care or (e) residence outside the health district. Eligible patients were mailed validated mood screening tools. High-scoring patients meeting predefined criteria were referred to a rapid-access psychiatry clinic. Results: Of 825 patients identified, 485 were eligible and 236 (49%) responded. Responders were older than non-responders (median 75 vs 71 years, p<0.01), and there was a trend towards fewer males (58% vs 66%, p=0.052). Among responders, 84 (35%) scored above thresholds for anxiety and/or depression. Of these, 18 (21%) were referred to psychiatry; 14 attended, and 10 (71%) received interventions, including initiation of medication and/or referral to psychology. Conclusions: Anxiety and depression were highly prevalent after stroke in our population. This pilot poststroke mood disorder screening was feasible, identified one in three responders with symptoms and led to targeted psychiatric interventions in the majority of those reviewed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.